Klofen PG Tablet SR is a sustained-release formulation combining Aceclofenac 200 mg and Pregabalin 75 mg, designed for the management of pain and inflammation associated with musculoskeletal disorders and neuropathic pain conditions. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and swelling. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channel function in the central nervous system, diminishing neurotransmitter release and providing effective neuropathic pain relief. This combination offers a dual mechanism of action, addressing both inflammatory and neuropathic components of pain, making it suitable for conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and diabetic neuropathy. The sustained-release formulation ensures prolonged drug release, enhancing patient compliance by reducing dosing frequency and maintaining consistent plasma drug levels. Klofen PG Tablet SR should be administered as prescribed by a healthcare professional, with caution advised in patients with a history of gastrointestinal ulcers, renal or hepatic impairment, and cardiovascular disorders. Regular monitoring is recommended to detect potential adverse effects, including gastrointestinal discomfort, dizziness, or allergic reactions. This combination therapy provides an effective and convenient option for comprehensive pain management in clinical practice.